Primary Clinical Research

05/28/2026

🎉 Big news!

We were officially fully enrolled (94 screened!), but the Sponsor just opened 15 MORE screening spots for PCR!

We’re STILL enrolling participants for our weight loss research study.

✅ No cost to participate
✅ Study-related care provided

Message us or call (402) 282-1502 to see if you qualify!

05/20/2026

🌟Happy Clinical Trials Day to the people who make our work meaningful.🌟

Today we celebrate the volunteers, staff, and partners who make clinical research possible. Every visit, every data point, and every conversation with a participant helps move science forward in ways that truly matter.

To our participants... thank you for your trust, your time, and your commitment to advancing research that may help future generations.

To our incredible team... your compassion, precision, and dedication ensure every study is conducted with care and integrity. We’re proud of the work we do, and even prouder of the people behind it.

At Primary Clinical Research, we’re honored to support studies across multiple areas of health, including:
• Menstrual Migraine
• COPD
• Asthma
• Cervical Hyperplasia
• Multiple weight‑loss clinical trials

If you or someone you know is interested in learning more about our studies, we’re here to help. 💙

05/12/2026

📣We are enrolling people living with excess weight or obesity and type 2 diabetes to help us learn if a GLP-1 weight loss study medicine, along with a healthy diet and exercise, can help reduce body weight.

Reach out to see if this clinical trial is right for you...

📧contact@pcresearch.health
☎️(402) 282-1502

05/05/2026

Reach out for more details and to see if you or a loved one may qualify!
☎️ (402) 282-1502
📧 contact@pcresearch.health

03/31/2026

COPD research is getting some love in the headlines — and we’re here for it.

We’re proud to be part of a study evaluating tozorakimab, an investigational option being explored for COPD.

Science + community = our favorite combo.

Friday's positive trial results for tozorakimab mark a significant inflexion point for AstraZeneca PLC (LSE:AZN, NASDAQ:AZN), arriving at a moment when the market had all but written off the drug's prospects and at a time when the pharmaceutical industry has been struggling to find treatments...

03/18/2026

🎉🎉🎉

03/17/2026

Luck was not on our side today… 🍀

But thankfully nobody was injured.

Shoutout to the amazing first responders who assisted! Thanks for your patience as we get appointments rescheduled. 🙏🏻

Unfortunately we will be closed the rest of today and tomorrow morning as a car accidentally drove into our building and repairs need to be made. Thank you for your understanding!

Edit: Praise Jesus not a single person was injured!!

01/19/2026

🕊️ Dr. Martin Luther King Jr. taught us that meaningful change happens when we serve others with purpose.

Our mission is rooted in that same belief — partnering with our community to advance health, expand access, and create opportunities for every patient to participate in research that shapes the future. ⚕️

Today, we honor his legacy by recommitting to that work. 🤍

01/04/2026

Join us in the pursuit to change patients’ lives. Each and every person in a clinical trial plays a powerful role.

12/24/2025

✨From our family to yours, we’re wrapping ourselves in holiday cheer (and a few ornaments 🎄) to wish you a season filled with warmth, laughter, and love. Merry Christmas and Happy Holidays! Thank you for being part of our journey… here’s to an amazing year ahead. ❤️

11/27/2025

📸 Teamwork makes the dream work! From all of us at Primary Clinical Research and McGill Family Practice, we’re grateful for each other… and for YOU. Wishing everyone a Happy Thanksgiving filled with joy, health, and togetherness! 🦃🍂